{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:15:38Z","timestamp":1783977338915,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Pr\u00e9cis:<\/jats:title>\n            <jats:p>In this retrospective cohort study, the 1-year cumulative probability of failure was comparable, achieving 52.20% in the phacoemulsification-iStent inject W (phaco\/iStent) group and 47.80% in the phacoemulsification-micropulse transscleral laser therapy (phaco\/MPTLT) group (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.994).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare the 1-year efficacy and safety of phacoemulsification combined with iStent Inject W (phaco\/iStent) and phacoemulsification combined with micropulse transscleral laser therapy (phaco\/MPTLT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective cohort study that included patients with mild-moderate open angle glaucoma (OAG) and cataract who underwent either phaco\/iStent or phaco\/MPTLT in a tertiary hospital in Singapore between August 1, 2016 and December 31, 2022. The primary outcome measures were cumulative probabilities of failure between the 2 groups, with failure defined as disease progression by ocular coherence tomography (OCT-RNFL) or visual field test (VFT), repeat glaucoma surgery, and inability to maintain intraocular pressure (IOP) lower than preoperative baseline or the use of glaucoma medications for 2 consecutive visits after 1 month postoperatively. In addition, postoperative mean IOP, average number of IOP lowering medications, visual acuity, and complications were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-six patients were included. Twenty-three eyes underwent phaco\/iStent and 23 had phaco\/MPTLT. The 2 groups had comparable cumulative probabilities of failure (52.20% phaco\/iStent, 47.80% phaco\/MPTLT; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.994) and mean IOP (15.57\u00b12.95\u00a0mm\u00a0Hg phaco \/iStent, 14.39\u00b12.25\u00a0mm\u00a0Hg phaco\/MPTLT; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.136) after 1 year. The change in IOP before surgery to 12 months is \u22121.04\u00b13.07\u00a0mm\u00a0Hg in the phaco\/iStent group (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.593) and \u22122.43\u00b14.12\u00a0mm\u00a0Hg in the phaco\/MPTLT group (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.022). Both achieved significant medication reduction burdens (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). Intraoperative and postoperative complication rates were similar.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Both groups showed comparable surgical efficacy and safety after 1 year. The phaco\/MPTLT group demonstrated sustained IOP reduction 1 year postoperatively.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ijg.0000000000002564","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T14:00:25Z","timestamp":1741788025000},"page":"428-432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Comparison Between Phacoemulsification-iStent Inject W and Phacoemulsification-Micropulse Transscleral Laser Therapy in Asian Eyes With Mild-Moderate Open Angle Glaucoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Michel M.","family":"Figueras","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"},{"name":"Department of Ophthalmology, Cardinal Santos Medical Center, Metro Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"},{"name":"Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai K.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"},{"name":"Department of Ophthalmology, Hospital Selayang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Aquino","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus C.J.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"},{"name":"Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine W.","family":"Lun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn K.A.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng C.","family":"Loon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.K.","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor T.","family":"Chang Koh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital, National University Health System"},{"name":"Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"R1-20250530","first-page":"415","article-title":"The new epidemiology of cataract","volume":"19","author":"Abraham","year":"2006","journal-title":"Ophthalmol Clin North Am"},{"key":"R3-20250530","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","article-title":"Prospective randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"R4-20250530","first-page":"1397","article-title":"iStent trabecular micro-bypass stent for open-angle glaucoma","volume":"8","author":"Le","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R5-20250530","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1177\/1120672120914231","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma.","volume":"31","author":"Tekeli","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R6-20250530","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ogla.2020.02.005","article-title":"The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma","volume":"3","author":"Kaba","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"R7-20250530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5005\/jp-journals-10028-1244","article-title":"Micropulse P3 laser for glaucoma: an innovative therapy","volume":"12","author":"Aquino","year":"2018","journal-title":"J Curr Glaucoma Pract"},{"key":"R8-20250530","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ceo.12360","article-title":"Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study","volume":"43","author":"Aquino","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-20250530","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","article-title":"Micropulse trans-scleral cyclophotocoagulation in the treatment of refractory glaucoma","volume":"38","author":"Tan","year":"2010","journal-title":"Colin Experim Ophthalmol"},{"key":"R10-20250530","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12886-023-02877-6","article-title":"Transscleral vs endoscopic cyclophotocoagulation: safety and efficacy when combined with phacoemulsification.","volume":"23","author":"Nirappel","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R11-20250530","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/s41433-021-01826-1","article-title":"Phacoemulsification combined with micropulse cyclodiode laser in glaucoma patients: efficacy and safety","volume":"36","author":"Daas","year":"2002","journal-title":"Eye"},{"key":"R12-20250530","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","article-title":"A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study","volume":"127","author":"Ahmed","year":"2020","journal-title":"Ophthalmology"},{"key":"R13-20250530","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s12325-019-01067-5","article-title":"One-year comparative evaluation of iStent or iStent inject implantation combined with cataract surgery in a single Center","volume":"36","author":"Guedes","year":"2019","journal-title":"Adv Ther"},{"key":"R14-20250530","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/bjophthalmol-2012-302394","article-title":"Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract","volume":"97","author":"Arriola-Villalobos","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R15-20250530","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/11206721211000641","article-title":"Combined phacoemulsification and iStent Inject implantation in Asian eyes","volume":"32","author":"Hu Jeremy","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"R16-20250530","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.2147\/OPTH.S403386","article-title":"Comparison of efficacy of combined phacoemulsification and iStent inject versus combined phacoemulsification and Hydrus microstent","volume":"17","author":"Chee","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"R17-20250530","first-page":"57","article-title":"Product spotlight: redesigned probe delivers consistency and simplification to IOP reduction","volume":"24","author":"Appold","year":"2020","journal-title":"Glaucoma Phys"},{"key":"R18-20250530","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10384-022-00938-9","article-title":"Short-term outcomes of micropulse transscleral laser therapy using revised delivery probe in refractory glaucoma","volume":"66","author":"Akiyama","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"R19-20250530","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","article-title":"Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?","volume":"112","author":"Robin","year":"2005","journal-title":"Ophthalmology"},{"key":"R20-20250530","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-020-00194-3","article-title":"iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience.","volume":"7","author":"Ferguson","year":"2020","journal-title":"Eye Vis"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0000000000002564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:00:35Z","timestamp":1748635235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0000000000002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0000000000002564","relation":{},"ISSN":["1057-0829","1536-481X"],"issn-type":[{"value":"1057-0829","type":"print"},{"value":"1536-481X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2024-09-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}